| Joseph Fredrick Morris, MD | |
|
1250 Keene Rd Ste 102, Nicholasville, KY 40356-7600 | |
| (859) 887-6752 | |
| (859) 887-6879 |
| Full Name | Joseph Fredrick Morris |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Experience | 36 Years |
| Location | 1250 Keene Rd Ste 102, Nicholasville, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477667269 | NPI | - | NPPES |
| 64310170 | Medicaid | KY | |
| 0149397 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 31017 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Hospital | Lexington, KY | Hospital |
| Saint Joseph East | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentuckyone Health Medical Group Inc | 8820993702 | 227 |
News Archive
Patients with nasopharyngeal cancer are at an increased risk for ischemic stroke, particularly if comorbidities are present, report researchers.
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
"The United Nations independent expert on access to water and sanitation as a human right on Saturday urged States to allocate more resources to improving sanitation and promote efficient use of existing hygiene facilities, stressing that people are entitled to decent toilets," the U.N. News Centre reports.
Flexion Therapeutics, Inc. today reported that its lead osteoarthritis drug candidate, FX005, demonstrated significant pain relief over placebo at four weeks in a Phase 2 proof-of-concept trial. Top-line data showed FX005, delivered intra-articularly to the knee, was well-tolerated and resulted in prolonged improvement in joint pain and function throughout the 12-week duration of the study.
Controlling mosquito-borne illnesses, such as Dengue or West Nile virus, has historically been difficult due to a lack of effective vaccines and concerns about the environmental impact of insecticides.
› Verified 4 days ago
| Entity Name | Kentuckyone Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104875970 PECOS PAC ID: 8820993702 Enrollment ID: O20031204000080 |
News Archive
Patients with nasopharyngeal cancer are at an increased risk for ischemic stroke, particularly if comorbidities are present, report researchers.
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
"The United Nations independent expert on access to water and sanitation as a human right on Saturday urged States to allocate more resources to improving sanitation and promote efficient use of existing hygiene facilities, stressing that people are entitled to decent toilets," the U.N. News Centre reports.
Flexion Therapeutics, Inc. today reported that its lead osteoarthritis drug candidate, FX005, demonstrated significant pain relief over placebo at four weeks in a Phase 2 proof-of-concept trial. Top-line data showed FX005, delivered intra-articularly to the knee, was well-tolerated and resulted in prolonged improvement in joint pain and function throughout the 12-week duration of the study.
Controlling mosquito-borne illnesses, such as Dengue or West Nile virus, has historically been difficult due to a lack of effective vaccines and concerns about the environmental impact of insecticides.
› Verified 4 days ago
| Entity Name | Meadowview Physician Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760893275 PECOS PAC ID: 9032276274 Enrollment ID: O20090316000259 |
News Archive
Patients with nasopharyngeal cancer are at an increased risk for ischemic stroke, particularly if comorbidities are present, report researchers.
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
"The United Nations independent expert on access to water and sanitation as a human right on Saturday urged States to allocate more resources to improving sanitation and promote efficient use of existing hygiene facilities, stressing that people are entitled to decent toilets," the U.N. News Centre reports.
Flexion Therapeutics, Inc. today reported that its lead osteoarthritis drug candidate, FX005, demonstrated significant pain relief over placebo at four weeks in a Phase 2 proof-of-concept trial. Top-line data showed FX005, delivered intra-articularly to the knee, was well-tolerated and resulted in prolonged improvement in joint pain and function throughout the 12-week duration of the study.
Controlling mosquito-borne illnesses, such as Dengue or West Nile virus, has historically been difficult due to a lack of effective vaccines and concerns about the environmental impact of insecticides.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Fredrick Morris, MD Po Box 936, London, KY 40743-0936 Ph: () - | Joseph Fredrick Morris, MD 1250 Keene Rd Ste 102, Nicholasville, KY 40356-7600 Ph: (859) 887-6752 |
News Archive
Patients with nasopharyngeal cancer are at an increased risk for ischemic stroke, particularly if comorbidities are present, report researchers.
Idera Pharmaceuticals, Inc. today announced results from its single-dose, dose-escalation Phase 1 clinical trial evaluating the safety and mechanism of action of IMO-3100, its lead Toll-like Receptor (TLR) 7 and TLR9 antagonist drug candidate for the treatment of autoimmune and inflammatory diseases.
"The United Nations independent expert on access to water and sanitation as a human right on Saturday urged States to allocate more resources to improving sanitation and promote efficient use of existing hygiene facilities, stressing that people are entitled to decent toilets," the U.N. News Centre reports.
Flexion Therapeutics, Inc. today reported that its lead osteoarthritis drug candidate, FX005, demonstrated significant pain relief over placebo at four weeks in a Phase 2 proof-of-concept trial. Top-line data showed FX005, delivered intra-articularly to the knee, was well-tolerated and resulted in prolonged improvement in joint pain and function throughout the 12-week duration of the study.
Controlling mosquito-borne illnesses, such as Dengue or West Nile virus, has historically been difficult due to a lack of effective vaccines and concerns about the environmental impact of insecticides.
› Verified 4 days ago
Saranne Perman, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 110 Village Pkwy, Nicholasville, KY 40356 Phone: 859-887-2484 Fax: 859-885-8448 | |
Dr. Jennifer L Beck, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Wind Haven Dr Ste 104, Nicholasville, KY 40356 Phone: 314-888-5233 Fax: 318-232-5983 | |
Ali Imran Cheema, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Orchard Dr, Nicholasville, KY 40356 Phone: 859-881-4288 Fax: 859-881-4388 | |
James Arthur Henderson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 110 Village Pkwy, Nicholasville, KY 40356 Phone: 859-887-2484 Fax: 859-885-8448 | |
Katharine Mcdowell Clemmer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Village Pkwy, Nicholasville, KY 40356 Phone: 859-867-8400 Fax: 859-885-8448 | |
Jonathan Adam Lewis, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 610 E Brannon Rd, Nicholasville, KY 40356 Phone: 859-260-5540 Fax: 859-260-4399 |